Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of mutations. Although some of these alterations should be recognized as a threat by ...

An international research group has developed a new method to help the immune system recognise and attack cancer cells by ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...

In experiments with mice, this method was shown to be effective in activating the immune system to target and destroy cancer cells, slowing down tumour growth. When combined with existing ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Now we know that the treatment works in principle in mice, researchers can continue to develop this immunotherapy to make it suitable for people, as well as to understand the full effect it could have ...

A study from St. Jude Children’s Research Hospital reveals that the protein VDAC2 acts as a “signal jammer” in tumors, ...

Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...

New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors. The gut microbes can affect the immune system.

"We have shown that our approach is more effective than conventional BCG treatment in mice, which is a breakthrough in immunotherapy for this type of cancer," explains Samuel Sánchez, ICREA ...